Delivery Order SPE2DB22D3004-SPE2DB25FNE30

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FNE30
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product QUVIVIQ 50 MG TABLET 30S. The contract has a ceiling value of $1,856.37 and a period of performance through October 11, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs. The company holds several large Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, that serve as primary vehicles for delivering essential pharmaceutical and medical products to federal agencies.

Generated 1/9/25, 9:24 AM